These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 37253115)

  • 1. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
    Pofi R; Caratti G; Ray DW; Tomlinson JW
    Endocr Rev; 2023 Nov; 44(6):975-1011. PubMed ID: 37253115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.
    Stulnig TM; Waldhäusl W
    Diabetologia; 2004 Jan; 47(1):1-11. PubMed ID: 14652720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
    Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
    Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
    van Raalte DH; Ouwens DM; Diamant M
    Eur J Clin Invest; 2009 Feb; 39(2):81-93. PubMed ID: 19200161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of glucocorticoid action and the treatment of type-2 diabetes.
    Tomlinson JW; Stewart PM
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):607-19. PubMed ID: 18054738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory.
    Seckl JR; Walker BR
    Trends Endocrinol Metab; 2004 Nov; 15(9):418-24. PubMed ID: 15519888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
    Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
    J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes.
    Morgan SA; Tomlinson JW
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1067-76. PubMed ID: 20707593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.
    Morgan SA; Hassan-Smith ZK; Lavery GG
    Eur J Endocrinol; 2016 Aug; 175(2):R83-9. PubMed ID: 26957494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus.
    Li X; Wang J; Yang Q; Shao S
    Am J Med Sci; 2017 Oct; 354(4):408-414. PubMed ID: 29078846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions.
    Li JX; Cummins CL
    Nat Rev Endocrinol; 2022 Sep; 18(9):540-557. PubMed ID: 35585199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
    Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
    Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.
    Aubry EM; Odermatt A
    Endocrinology; 2009 Jun; 150(6):2700-8. PubMed ID: 19179438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.